Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources

The treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. In addition, there is a lack of consensus on the treatment of hypopigmented MF (HMF), which is a frequentl...

Full description

Bibliographic Details
Main Authors: Mona Abdel-Halim Ibrahim, Nada Eltayeb, Mirna Michel Ibrahim, Ahmed Nassar, Maged Daruish, Maha El-Zimaity, Mahmoud El-Lithy, Ahmed Mostafa, Amal El-Afifi, Haitham Abdelbary, Mahira Hamdy El-Sayed
Format: Article
Language:English
Published: Hindawi Limited 2023-01-01
Series:Dermatology Research and Practice
Online Access:http://dx.doi.org/10.1155/2023/1360740
_version_ 1811165467007516672
author Mona Abdel-Halim Ibrahim
Nada Eltayeb
Mirna Michel Ibrahim
Ahmed Nassar
Maged Daruish
Maha El-Zimaity
Mahmoud El-Lithy
Ahmed Mostafa
Amal El-Afifi
Haitham Abdelbary
Mahira Hamdy El-Sayed
author_facet Mona Abdel-Halim Ibrahim
Nada Eltayeb
Mirna Michel Ibrahim
Ahmed Nassar
Maged Daruish
Maha El-Zimaity
Mahmoud El-Lithy
Ahmed Mostafa
Amal El-Afifi
Haitham Abdelbary
Mahira Hamdy El-Sayed
author_sort Mona Abdel-Halim Ibrahim
collection DOAJ
description The treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. In addition, there is a lack of consensus on the treatment of hypopigmented MF (HMF), which is a frequently encountered variant in our population. We aimed to develop regional treatment guidelines based on the international guidelines but modified to encompass the restricted treatment availability and our institutional experience. Special attention was also given to studies conducted on patients with skin phototype (III-IV). Treatment algorithm was formulated at Ain-Shams cutaneous lymphoma clinic through the collaboration of dermatologists, haematologists, and oncologists. Level of evidence is specified for each treatment option. For HMF, phototherapy is recommended as a first line treatment, while low-dose methotrexate is considered a second line. For early classical MF, we recommend Psoralen-ultraviolet A (PUVA), which is a well-tolerated treatment option in dark phenotype. Addition of either retinoic acid receptor (RAR) agonist and/or methotrexate is recommended as a second line. Total skin electron beam (TSEB) is considered a third-line option. For advanced stage, PUVA plus RAR agonist and/or methotrexate is recommended as first line, TSEB or monochemotherapy is considered a second line option. Polychemotherapy is regarded as a final option. All patients with complete response (CR) enter a maintenance and follow-up schedule. We suggest a practical algorithm for the treatment of MF for patients with dark phenotype living in countries with limited resources.
first_indexed 2024-04-10T15:37:35Z
format Article
id doaj.art-3cc74b88da6d4187aa415f547a961e8b
institution Directory Open Access Journal
issn 1687-6113
language English
last_indexed 2024-04-10T15:37:35Z
publishDate 2023-01-01
publisher Hindawi Limited
record_format Article
series Dermatology Research and Practice
spelling doaj.art-3cc74b88da6d4187aa415f547a961e8b2023-02-13T01:08:39ZengHindawi LimitedDermatology Research and Practice1687-61132023-01-01202310.1155/2023/1360740Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited ResourcesMona Abdel-Halim Ibrahim0Nada Eltayeb1Mirna Michel Ibrahim2Ahmed Nassar3Maged Daruish4Maha El-Zimaity5Mahmoud El-Lithy6Ahmed Mostafa7Amal El-Afifi8Haitham Abdelbary9Mahira Hamdy El-Sayed10Dermatology DepartmentDermatology DepartmentDermatology DepartmentDermatology DepartmentDepartment of DermatopathologyHematology DepartmentOncology DepartmentOncology DepartmentHematology DepartmentHematology DepartmentDermatology DepartmentThe treatment options for mycosis fungoides (MF) have been expanding but unfortunately many of the currently used treatment modalities are unavailable in Egypt and other African/Arab countries. In addition, there is a lack of consensus on the treatment of hypopigmented MF (HMF), which is a frequently encountered variant in our population. We aimed to develop regional treatment guidelines based on the international guidelines but modified to encompass the restricted treatment availability and our institutional experience. Special attention was also given to studies conducted on patients with skin phototype (III-IV). Treatment algorithm was formulated at Ain-Shams cutaneous lymphoma clinic through the collaboration of dermatologists, haematologists, and oncologists. Level of evidence is specified for each treatment option. For HMF, phototherapy is recommended as a first line treatment, while low-dose methotrexate is considered a second line. For early classical MF, we recommend Psoralen-ultraviolet A (PUVA), which is a well-tolerated treatment option in dark phenotype. Addition of either retinoic acid receptor (RAR) agonist and/or methotrexate is recommended as a second line. Total skin electron beam (TSEB) is considered a third-line option. For advanced stage, PUVA plus RAR agonist and/or methotrexate is recommended as first line, TSEB or monochemotherapy is considered a second line option. Polychemotherapy is regarded as a final option. All patients with complete response (CR) enter a maintenance and follow-up schedule. We suggest a practical algorithm for the treatment of MF for patients with dark phenotype living in countries with limited resources.http://dx.doi.org/10.1155/2023/1360740
spellingShingle Mona Abdel-Halim Ibrahim
Nada Eltayeb
Mirna Michel Ibrahim
Ahmed Nassar
Maged Daruish
Maha El-Zimaity
Mahmoud El-Lithy
Ahmed Mostafa
Amal El-Afifi
Haitham Abdelbary
Mahira Hamdy El-Sayed
Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
Dermatology Research and Practice
title Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
title_full Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
title_fullStr Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
title_full_unstemmed Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
title_short Suggested Guidelines for the Treatment of Mycosis Fungoides in Countries with Limited Resources
title_sort suggested guidelines for the treatment of mycosis fungoides in countries with limited resources
url http://dx.doi.org/10.1155/2023/1360740
work_keys_str_mv AT monaabdelhalimibrahim suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT nadaeltayeb suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT mirnamichelibrahim suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT ahmednassar suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT mageddaruish suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT mahaelzimaity suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT mahmoudellithy suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT ahmedmostafa suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT amalelafifi suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT haithamabdelbary suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources
AT mahirahamdyelsayed suggestedguidelinesforthetreatmentofmycosisfungoidesincountrieswithlimitedresources